NASDAQ · Healthcare · Biotechnology
Aurinia Pharmaceuticals Inc.
AUPH
Aurinia Pharmaceuticals Inc. CEO Kevin C. Tang · Market cap $2.2B.
$17.23
-0.32 · -1.82%
52w hi $19.2552w lo $7.29
Off 52w high 8.8%
54
ROUTINE
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $12.60
Section 01
Recent Form 4 filings
12 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 02 | TANG KEVIN | Chief Executive Officer | Buy | 206,005 | $15.28 | +$3.15M | 51 |
| Jun 01 | TANG KEVIN | Chief Executive Officer | Buy | 343,521 | $15.28 | +$5.25M | 54 |
| May 29 | TANG KEVIN | Chief Executive Officer | Buy | 2,299 | $15.35 | +$35K | 40 |
| May 29 | TANG KEVIN | Chief Executive Officer | Buy | 262,682 | $15.31 | +$4.02M | 51 |
| Mar 03 | TANG KEVIN | Buy | 184,208 | $14.22 | +$2.62M | 42 | |
| Mar 02 | TANG KEVIN | Buy | 83,561 | $14.33 | +$1.20M | 42 | |
| Mar 02 | TANG KEVIN | Buy | 115,792 | $14.21 | +$1.65M | 42 | |
| Feb 27 | TANG KEVIN | Buy | 300,000 | $13.90 | +$4.17M | 42 | |
| Feb 27 | TANG KEVIN | Buy | 214,839 | $14.12 | +$3.03M | 42 | |
| Aug 05 | TANG KEVIN | Buy | 200,000 | $11.68 | +$2.34M | 42 | |
| Aug 04 | TANG KEVIN | Buy | 100,000 | $11.34 | +$1.13M | 42 | |
| Aug 01 | TANG KEVIN | Buy | 1,000,000 | $10.12 | +$10.12M | 48 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun